Oppenheimer & Co’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Oppenheimer & Co’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,579	Closed	-$255K	–	1620
2015 Q1	$255K	Sell	6,579 -183	-3%	-$7.05K	0.01%	1170
2014 Q4	$228K	Sell	6,762 -1,000	-13%	-$35.3K	0.01%	1155
2014 Q3	$272K	Hold	7,762	–	–	0.01%	1117
2014 Q2	$255K	Buy	7,762 +452	+6%	+$15.5K	0.01%	1138
2014 Q1	$269K	Sell	7,310 -1,672	-19%	-$61.4K	0.01%	1086
2013 Q4	$345K	Sell	8,982 -1,458	-14%	-$46K	0.01%	959
2013 Q3	$286K	Buy	+10,440	New	+$247K	0.01%	994

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Oppenheimer & Co's WX Position: Q2 2015 in Review

Oppenheimer & Co sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 6,579 shares — an estimated $255K sold.

Oppenheimer & Co first reported a position in WX in Q3 2013 and held it in 7 quarters. The position peaked at $345K in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Oppenheimer & Co reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
Oppenheimer & Co sold 6,579 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $255K.
Oppenheimer & Co first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 7 quarters.
Oppenheimer & Co's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $345K in Q4 2013.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.